Statistics for Aker BioMarine AS (id:10354 AKBM)
Valuation metrics
Market cap
5.95B
Enterprise value
67.44B
Trailing P/E (ttm)
205.76
Forward P/E
377.22
PEG ratio
377.22
Price/Sales (ttm)
17.78
Price/Book (mrq)
31.32
Enterprise Value/Revenue
18.15
Enterprise Value/EBITDA
129.84
Overview
Shares outstanding
87.68M
Float
11.82M
Shares short
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
56.89K
Average volume (90 days)
Price summary
52-Week low
42.15
52-Week high
109.80
52-Week change
32.16%
Beta
3.00
50-Day moving average
53.12
200-Day moving average
70.59
Dividends and splits
Forward annual dividend rate
180.00
Forward annual dividend yield
2.74
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
September 9, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
61.59%
Operating margin
1.22%
Operational effectiveness
Return on assets
3.00%
Return on equity
3.00%
Income statement
Revenue (ttm)
3.86
Revenue per share (ttm)
3.86
Quarterly revenue growth (yoy)
187.64
Gross profit (ttm)
112.90M
EBITDA
42.80M
Net income to common (ttm)
28.86M
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
18.76K%
Balance sheet
Total cash (mrq)
165.36M
Total cash per share (mrq)
3.00
Total debt (mrq)
1.67B
Total Debt/Equity (mrq)
79.18
Current ratio (mrq)
367.90%
Book value per share (mrq)
2.17
Cash flow
Cash flow statement
576.00M
Levered free cash flow (LFCF)
1.02B